LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN

The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.

Saved in:
Bibliographic Details
Main Authors LEE KWANGHO, SINGH JUSWINDER, ZHU ZHENDONG, NIU DEQIANG, QIAO LIXIN, PETTER RUSSELL C, JEWELL CHARLES F, MEDIKONDA ARAVIND PRASAD
Format Patent
LanguageEnglish
Published 03.11.2011
Subjects
ANALOGUE COMPUTERS
CALCULATING
CHEMISTRY
COMPUTING
COUNTING
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
Bibliography:Application Number: US20100982352